CLINICAL_TRIALS
trial_result
· 2019-01-31
Clinical Trial Update: Volasertib + Decitabine in Patients With Acute Myeloid Leukemia (AML) [Phase 1]
Summary
A Phase 1 trial evaluating Volasertib plus Decitabine in adults with acute myeloid leukemia has been terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Leukemia, Myeloid, Acute | Phase 1 | Status: TERMINATED | Results posted: 2019-01-31